Personalized Oncology Through Integrative High-Throughput Sequencing: A Pilot StudySameek Roychowdhury, Arul M. Chinnaiyan, Matthew K. Iyer et al.|Science Translational Medicine|2011Cited by 637
The MD Anderson Prostate Cancer Patient-derived Xenograft Series (MDA PCa PDX) Captures the Molecular Landscape of Prostate Cancer and Facilitates Marker-driven Therapy DevelopmentNallasivam Palanisamy, Nora M. Navone, Patricia Troncoso et al.|Clinical Cancer Research|2020Cited by 86
Integrative Molecular Analyses of the MD Anderson Prostate Cancer Patient-derived Xenograft (MDA PCa PDX) SeriesNicolás Anselmino, Nora M. Navone, Estefanía Labanca et al.|Clinical Cancer Research|2024Cited by 28
High-Dose Chemotherapy for Multiply or Poor-Risk Relapsed Germ Cell TumorsYago Nieto, Matthew T. Campbell, John F. Ward et al.|Clinical Cancer Research|2025Cited by 2
Data from Integrative Molecular Analyses of the MD Anderson Prostate Cancer Patient-derived Xenograft (MDA PCa PDX) SeriesNicolás Anselmino, Nora M. Navone, Estefanía Labanca et al.|Unknown|2024Cited by 1